Legal Representation
Attorney
M. Scott Alprin
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 18, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 18, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 12, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 22, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 22, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 22, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 22, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 22, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 17, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 6, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 6, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 30, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| May 30, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment and prevention of rheumatic disorders, oncological diseases, auto-immune diseases, endocrine disorders, reproductive diseases, hematologic diseases, neurological disorders, renal and urologic disorders, cardiovascular and lymphatic diseases, digestive disorders, musculoskeletal disorders, infectious diseases, pain conditions, pulmonary diseases and integumentary diseases; Veterinary pharmaceutical preparations for the treatment of rheumatic disorders, oncological diseases, auto-immune diseases, endocrine disorders, reproductive diseases, hematologic diseases, neurological disorders, renal and urologic disorders, cardiovascular and lymphatic diseases, digestive disorders, musculoskeletal disorders, infectious diseases, pain conditions, pulmonary diseases and integumentary diseases; Veterinary pharmaceutical preparations for the prevention of rheumatic disorders, oncological diseases, auto-immune diseases, endocrine disorders, reproductive diseases, hematologic diseases, neurological disorders, renal and urologic disorders, cardiovascular and lymphatic diseases, digestive disorders, musculoskeletal disorders, infectious diseases, pain conditions, pulmonary diseases and integumentary diseases
First Use Anywhere:
Mar 25, 2025
First Use in Commerce:
May 28, 2025
Additional Information
Design Mark
The mark consists of stylized wording "Eywa Hibrow" in larger font above the stylized word "PHARMA" in smaller font, with the wording "Eywa" bisecting the shape of an outer crescent moon facing to the right on the left side of the mark, and with the word "Hibrow" bisecting the shape of a second inner crescent moon, facing to the left on the right side of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
PHARMA